Feb 7 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2019 Dec 31, 2018 Dec 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 169 mln 8 mln 234 mln 234 mln
(+1922.9 pct) (-95.8 pct) (+37.9 pct) (+711.0 pct)
Operating loss 1.63 loss 1.27 loss 1.19 loss 590 mln
Recurring loss 1.63 loss 1.29 loss 1.19 loss 592 mln
Net
Net loss 1.62 loss 1.27 loss 1.19 loss 593 mln
EPS loss 134.32 yen loss 126.77 yen loss 86.88 yen loss 42.29 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T